Joint United Nations Programme on HIV/AIDS (UNAIDS). Together We Will End AIDS. Geneva: UNAIDS; 2012.
World Health Organization (WHO), United Nations Children’s Fund (UNICEF), Joint United Nations Programme on HIV/AIDS (UNAIDS). Global HIV/AIDS Response: Epidemic Update and Health Sectors Progress Towards Universal Access. Progress Report 2011. Geneva: WHO; 2011.
Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;25(5):331–42.
Article
Google Scholar
Haynes RB, McDonald H, Garg AX. Montegue P. Cochrane Database Syst Rev: Interventions for helping patients to follow prescriptions for medications; 2002 (2):CD000011. [NOTE: updated 2005;(4):CD000011.].
Google Scholar
DeMaria AN. Adherence, compliance, concordance, or the lack thereof. J Am Coll Cardiol. 2012;59(12):1120–1.
PubMed
Article
Google Scholar
Aronson JK. Compliance, concordance, adherence. Br J Clin Pharmacol. 2007;63(4):383–4.
PubMed
Article
PubMed Central
Google Scholar
Bell SJ, Airaksinen MS, Lyles A, Chen TF, Aslani P. Concordance is not synonymous with compliance or adherence. Br J Clin Pharmacol. 2007;64(5):710–1.
PubMed
Article
PubMed Central
Google Scholar
Steiner EM, Earnest MA. The language of medication-taking. Ann Intern Med. 2000;132:926–30.
PubMed
Article
CAS
Google Scholar
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.
PubMed
Article
CAS
Google Scholar
Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–7.
PubMed
Article
Google Scholar
Bissell P, May CR, Noyce PR. From compliance to concordance: barriers to accomplishing a re-framed model of health care interactions. Soc Sci Med. 2004;58(4):851–62.
PubMed
Article
Google Scholar
World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: WHO; 2003.
Google Scholar
Lamb MR, El-Sadr WM, Geng E, Nash D. Association of adherence support and outreach services with total attrition, loss to follow-up, and death among ART patients in sub-Saharan Africa. PLoS One. 2012;7(6):e38443.
PubMed
Article
CAS
PubMed Central
Google Scholar
Chi BH, Cantrell RA, Mwango A, et al. An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs. Am J Epidemiol. 2010;171(8):924–31.
PubMed
Article
PubMed Central
Google Scholar
Chi BH, Yiannoutsos CT, Westfall AO, et al. Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America. PLoS Med. 2011;8(10):e1001111.
PubMed
Article
PubMed Central
Google Scholar
Fairman K, Motheral B. Evaluating medication adherence: which measure is right for your program? J Manage Care Pharm. 2000;6:499–504.
Google Scholar
Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S79–87.
PubMed
Article
PubMed Central
Google Scholar
Miller LG, Hays RD. Measuring adherence to antiretroviral medications in clinical trials. HIV Clin Trials. 2000;1(1):36–46.
PubMed
Article
CAS
Google Scholar
Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis. 2002;34(8):1115–21.
PubMed
Article
Google Scholar
Balkrishnan R. Predictors of medication adherence in the elderly. Clin Ther. 1998;20(4):764–71.
PubMed
Article
CAS
Google Scholar
Holzemer WL, Corless IB, Nokes KM, et al. Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care STDS. 1999;13(3):185–97.
PubMed
Article
CAS
Google Scholar
Stone VE, Hogan JW, Schuman P, et al. Antiretroviral regimen complexity, self-reported adherence, and HIV patients’ understanding of their regimens: survey of women in the her study. J Acquir Immune Defic Syndr. 2001;28(2):124–31.
PubMed
Article
CAS
Google Scholar
Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288(4):462–7.
PubMed
Article
Google Scholar
Cramer J, Rosenheck R, Kirk G, Krol W, Krystal J, VA Naltrexone Study Group 425. Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. Value Health. 2003;6(5):566–73.
PubMed
Article
Google Scholar
Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679–90.
PubMed
Article
CAS
Google Scholar
Ortego C, Huedo-Medina TB, Llorca J, et al. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011;15(7):1381–96.
PubMed
Article
Google Scholar
DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200–9.
PubMed
Article
Google Scholar
Coenen T, Lundgren J, Lazarus JV, Matic S. Optimal HIV testing and earlier care: the way forward in Europe. HIV Med. 2008;9(Suppl 2):1–5.
PubMed
Article
Google Scholar
US Centers for Disease Control and Prevention (CDC). HIV surveillance—United States, 1981–2008. Morb Mortal Wkly Rep. 2011;60(21):689–93.
Google Scholar
Girardi E, Sabin CA, Monforte AD. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr. 2007;46(Suppl 1):S3–8.
PubMed
Article
Google Scholar
Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011;8(7):e1001056.
PubMed
Article
PubMed Central
Google Scholar
Gardner EM, McLees MP, Steiner JF, del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800.
PubMed
Article
PubMed Central
Google Scholar
Ingle SM, May M, Uebel K, et al. Outcomes in patients waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage study. AIDS. 2010;24(17):2717–25.
PubMed
Article
PubMed Central
Google Scholar
Lawn SD, Myer L, Harling G, Orrell C, Bekker LG, Wood R. Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clin Infect Dis. 2006;43(6):770–6.
PubMed
Article
Google Scholar
Thai S, Koole O, Un P, et al. Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia. Trop Med Int Health. 2009;14(9):1048–58.
PubMed
Article
Google Scholar
Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007–2009: systematic review. Trop Med Int Health. 2010;15(Suppl 1):1–15.
PubMed
Article
PubMed Central
Google Scholar
Urquhart J. Defining the margins for errors in patient compliance with prescribed drug regimens. Pharmacoepidemiol Drug Saf. 2000;9(7):565–8.
PubMed
Article
CAS
Google Scholar
Paes AH, Bakker A, Soe-Agnie CJ. Measurement of patient compliance. Pharm World Sci. 1998;20(2):73–7.
PubMed
Article
CAS
Google Scholar
Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21(6):1074–90.
PubMed
Article
CAS
Google Scholar
Vitolins MZ, Rand CS, Rapp SR, Ribisl PM, Sevick MA. Measuring adherence to behavioral and medical interventions. Control Clin Trials. 2000;21(Suppl 5):S188–94.
Article
Google Scholar
Nunnally JC, Berstein I. Psychometric theory. 3rd ed. New York: McGraw-Hill; 1994.
Google Scholar
McMahon JH, Jordan MR, Kelley K, et al. Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring. Clin Infect Dis. 2011;52(4):493–506.
PubMed
Article
PubMed Central
Google Scholar
Chalker JC, Andualem T, Gitau LN, et al. Measuring adherence to antiretroviral treatment in resource-poor settings: the feasibility of collecting routine data for key indicators. BMC Health Serv Res. 2010;19(10):43.
Article
Google Scholar
Ross-Degnan D, Pierre-Jacques M, Zhang F, et al. Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators. BMC Health Serv Res. 2010;19(10):42.
Article
Google Scholar
Steel G, Nwokike J, Joshi MP. Development of a Multi-Method Tool to Measure ART Adherence in Resource-Constrained Settings: The South Africa Experience. Submitted to the USAID by RPM plus. Arlington, Va: Management Sciences for Health; 2007.
Herbst AJ, Cooke GS, Bärnighausen T, KanyKany A, Tanser F, Newell ML. Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa. Bull World Health Organ. 2009;87(10):754–62.
PubMed
Article
PubMed Central
Google Scholar
Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med. 1997;337(11):725–33.
PubMed
Article
CAS
Google Scholar
Michaels SH, Clark R, Kissinger P. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;339(6):405–6.
PubMed
Article
CAS
Google Scholar
Chan KC, Wong KH, Lee SS. Universal decline in mortality in patients with advanced HIV-1 disease in various demographic subpopulations after the introduction of HAART in Hong Kong, from 1993 to 2002. HIV Med. 2006;7(3):186–92.
PubMed
Article
CAS
Google Scholar
World Health Organization (WHO). WHO Global Strategy for Containment of Antimicrobial Resistance. Geneva: WHO; 2001.
Phillips A, Pezzotti P. CASCADE Collaboration. Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era. AIDS. 2004;18(1):51–8.
PubMed
Article
CAS
Google Scholar
Sabin CA, Smith CJ, Gumley H, et al. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS. 2004;18(16):2145–51.
PubMed
Article
Google Scholar
Hocking JS, Rodger AJ, Rhodes DG, Crofts N. Late presentation of HIV infection associated with prolonged survival following AIDS diagnosis—characteristics of individuals. Int J STD AIDS. 2000;11(8):503–8.
PubMed
Article
CAS
Google Scholar
Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181–3.
PubMed
Article
CAS
Google Scholar
de Olalla PG, Knobel H, Carmona A, Guelar A, López-Colomés JL, Caylà JA. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acquir Immune Defic Syndr. 2002;30(1):105–10.
Article
Google Scholar
Hoggs RS, Heath K, Bangsberg D, et al. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS. 2002;16(7):1051–8.
Article
Google Scholar
Grossberg R, Zhang Y, Gross R. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol. 2004;57(10):1107–10.
PubMed
Article
Google Scholar
Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30.
PubMed
Article
CAS
Google Scholar
Nachega JB, Hislop M, Dowdy DW, et al. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr. 2006;43(1):78–84.
PubMed
Article
Google Scholar
Giordano TP, Gifford AL, White AC Jr, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. 2007;44(11):1493–9.
PubMed
Article
Google Scholar
Bangsberg DR, Moss AR, Deeks SG. Paradoxes of adherence and drug resistance to HIV antiretroviral therapy. J Antimicrob Chemother. 2004;53(5):696–9.
PubMed
Article
CAS
Google Scholar
Green DA. There are no paradoxes of adherence and drug resistance to HIV antiretroviral therapy. J Antimicrob Chemother. 2004;54(3):694.
PubMed
Article
CAS
Google Scholar
Bangsberg DR, Kroetz DL, Deeks SG. Adherence-resistance relationships to combination HIV antiretroviral therapy. Curr HIV/AIDS Rep. 2007;4(2):65–72.
PubMed
Article
Google Scholar
Gardner EM, Burman WJ, Steiner JF, Anderson PL, Bangsberg DR. Antiretroviral medication adherence and the development of class-specific antiretroviral resistance. AIDS. 2009;23(9):1035–46.
PubMed
Article
PubMed Central
Google Scholar
Gardner EM, Sharma S, Peng G, et al. Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance. AIDS. 2008;22(1):75–82.
PubMed
Article
CAS
PubMed Central
Google Scholar
World Health Organization (WHO). Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2010 Revision. Geneva: WHO; 2010. p. 2010.
Google Scholar
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Washington, DC: US Department of Health and Human Services; 2012.
Google Scholar
Tang JW, Pillay D. Transmission of HIV-1 drug resistance. J Clin Virol. 2004;30(1):1–10.
PubMed
Article
CAS
Google Scholar
World Health Organization (WHO). WHO HIV Drug Resistance Report 2012. Geneva: WHO; 2012.
Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.
PubMed
Article
CAS
PubMed Central
Google Scholar
Attia S, Egger M, Müller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009;23(11):1397–404.
PubMed
Article
Google Scholar
Donnell D, Baeten JM, Kiarie J, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375(9731):2092–8.
PubMed
Article
PubMed Central
Google Scholar
Nachega JB, Leisegang R, Bishai D, et al. Association of antiretroviral therapy adherence and health care cost. Ann Intern Med. 2010;152(1):18–25.
PubMed
Article
Google Scholar
Knobel H, Carmona A, Guelar A, Gonzolez A, Hernecki J, Diez A. Adherence in patients treated with HAART: influence in hospital admissions. Durban: International AIDS Conference; 2000 [abstract MoPeD2556].
Google Scholar
Long L, Fox M, Sanne I, Rosen S. The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa. AIDS. 2010;24(6):915–9.
PubMed
Article
Google Scholar
World Health Organization (WHO), Joint United Nations Programme on HIV/AIDS (UNAIDS). The Treatment 2.0 Framework for Action: Catalysing the Next Phase of Treatment, Care and Support. Geneva: WHO; 2011.
Coleman CI, Roberts MS, Sobieraj DM, Lee S, Alam T, Kaur R. Effect of dosing frequency on chronic cardiovascular disease medication adherence. Curr Med Res Opin. 2012;28(5):669–80.
PubMed
Article
CAS
Google Scholar
Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296–310.
PubMed
Article
CAS
Google Scholar
Reginster JY, Rabenda V, Neuprez A. Adherence, patient preference and dosing frequency: understanding the relationship. Bone. 2006;4(Suppl 1):S2–6.
Article
Google Scholar
Ma A, Chen DM, Chau FM, Saberi P. Improving adherence and clinical outcomes through an HIV pharmacist’s interventions. AIDS Care. 2010;22(19):1189–94.
PubMed
Article
Google Scholar
Kigozi IM, Dobkin LM, Martin JN, et al. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in sub-Saharan Africa. J Acquir Immune Defic Syndr. 2009;52(2):280–9.
PubMed
Article
PubMed Central
Google Scholar
Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009;360(18):1815–26.
PubMed
Article
CAS
PubMed Central
Google Scholar
Jani AV, Sitoe AE, Alfai ER, et al. Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet. 2011;378(9802):1572–9.
PubMed
Article
Google Scholar
Joint United Nations Programme on HIV/AIDS (UNAIDS). Breaking News Supplement: Meeting the Investment Challenge. Geneva: UNAIDS; 2012.
Torpey K, Kabaso M, Kasonde P, et al. Increasing the uptake of prevention of mother-to-child transmission of HIV services in a resource-limited setting. BMC Health Serv Res. 2010;10:29.
PubMed
Article
PubMed Central
Google Scholar
Killam WP, Tambatamba BC, Chintu N, et al. Antiretroviral therapy in antenatal care to increase treatment initiation in HIV-infected pregnant women: a stepped-wedge evaluation. AIDS. 2010;24(1):85–91.
PubMed
Article
Google Scholar
Louwagie G, Girdler-Brown B, Odendaal R, Rossouw T, Johnson S, Van der Walt M. Missed opportunities for accessing HIV care among Tshwane tuberculosis patients under different models of care. Int J Tuberc Lung Dis. 2012;16(8):1052–8.
PubMed
Article
CAS
Google Scholar
Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N, Weiser SD. Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study. AIDS Behav. 2010;14(4):778–84.
PubMed
Article
PubMed Central
Google Scholar
Hardon AP, Akurut D, Comoro C, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19(5):658–65.
PubMed
Article
CAS
Google Scholar
Ware NC, Idoko J, Kaaya S, et al. Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med. 2009;6(1):e1000011.
Article
PubMed Central
Google Scholar
Wouters E, Van Damme W, van Rensburg D, Meulemans H. Impact of baseline health and community support on antiretroviral treatment outcomes in HIV patients in South Africa. AIDS. 2008;22(18):2545–8.
PubMed
Article
Google Scholar
Decroo T, Telfer B, Biot M, et al. Distribution of antiretroviral treatment through self-forming groups of patients in Tete province, Mozambique. J Acquir Immune Defic Syndr. 2011;56(2):e39–44.
PubMed
Article
Google Scholar
United Nations General Assembly. Political Declaration on HIV and AIDS: Intensifying Our Efforts to Eliminate HIV and AIDS. New York: United Nations General Assembly; 2011.
Google Scholar
Joint United Nations Programme on HIV/AIDS (UNAIDS). Getting to Zero: 2011-2015 Strategy. Geneva: UNAIDS; 2010.